{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T12:00:20Z","timestamp":1775908820724,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003995","name":"Anhui Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2308085MH310"],"award-info":[{"award-number":["2308085MH310"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejmech.2025.118080","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T23:31:54Z","timestamp":1755905514000},"page":"118080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Design, synthesis, and biological evaluation of highly potent and selective hMAO-B inhibitors featuring a tetrahydrobenzo[f][1,4]oxazepine core"],"prefix":"10.1016","volume":"299","author":[{"given":"Mingxing","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Peng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing Xing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhouling","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajun","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7080-1768","authenticated-orcid":false,"given":"Chenzhong","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118080_bib1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pnpbp.2016.02.005","article-title":"Molecular aspects of monoamine oxidase B","volume":"69","author":"Ramsay","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejmech.2025.118080_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116180","article-title":"A second life for MAO inhibitors? From CNS diseases to anticancer therapy","volume":"267","author":"Sblano","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118080_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101256","article-title":"Monoamine oxidases in age-associated diseases: new perspectives for old enzymes","volume":"66","author":"Santin","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejmech.2025.118080_bib4","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.2174\/156802612805220011","article-title":"History and therapeutic use of MAO-A inhibitors: a historical perspective of mao-a inhibitors as antidepressant drug","volume":"12","author":"Y\u00e1\u00f1ez","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118080_bib5","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s11033-025-10349-x","article-title":"Molecular pathways: the quest for effective MAO-B inhibitors in neurodegenerative therapy","volume":"52","author":"Oyovwi","year":"2025","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ejmech.2025.118080_bib6","doi-asserted-by":"crossref","first-page":"6717","DOI":"10.1021\/jm501690r","article-title":"New frontiers in selective human MAO-B inhibitors","volume":"58","author":"Carradori","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118080_bib7","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3233\/JPD-212976","article-title":"Monoamine Oxidase-B inhibitors for the treatment of Parkinson's disease: past, present, and future","volume":"12","author":"Tan","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.ejmech.2025.118080_bib8","doi-asserted-by":"crossref","first-page":"36849","DOI":"10.1074\/jbc.M110.169482","article-title":"Potentiation of ligand binding through cooperative effects in monoamine oxidase B","volume":"285","author":"Bonivento","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118080_bib9","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1021\/jm070677y","article-title":"Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs","volume":"50","author":"Binda","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118080_bib10","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.drudis.2018.01.033","article-title":"Safinamide: a new hope for Parkinson's disease?","volume":"23","author":"Teixeira","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2025.118080_bib11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s40261-021-01011-y","article-title":"Overall efficacy and safety of safinamide in Parkinson's disease: a systematic review and a meta-analysis","volume":"41","author":"Giossi","year":"2021","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.ejmech.2025.118080_bib12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.brainresbull.2020.12.018","article-title":"Safinamide in neurological disorders and beyond: evidence from preclinical and clinical studies","volume":"168","author":"Wasan","year":"2021","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejmech.2025.118080_bib13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1468-1331.2012.03840.x","article-title":"Long-term efficacy and safety of safinamide as add-on therapy in early Parkinson's disease","volume":"20","author":"Schapira","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ejmech.2025.118080_bib14","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s00702-018-1853-9","article-title":"Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson's disease","volume":"125","author":"Sz\u00f6k\u0151","year":"2018","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejmech.2025.118080_bib15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/B978-0-12-386467-3.00009-1","article-title":"Selective inhibitors of monoamine oxidase type B and the \u201ccheese effect\u201d","volume":"100","author":"Finberg","year":"2011","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.ejmech.2025.118080_bib16","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2174\/1570159X16666180830100754","article-title":"Different generations of Type-B monoamine oxidase inhibitors in Parkinson's disease: from bench to bedside","volume":"17","author":"Alborghetti","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejmech.2025.118080_bib17","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.bmcl.2019.02.008","article-title":"Design, synthesis and biological evaluation of novel human monoamine oxidase B inhibitors based on a fragment in an X-ray crystal structure","volume":"29","author":"Cheng","year":"2019","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.118080_bib18","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.bmcl.2019.02.030","article-title":"Discovery of novel 2,3-dihydro-1H-inden-1-amine derivatives as selective monoamine oxidase B inhibitors","volume":"29","author":"Li","year":"2019","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.118080_bib19","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ejmech.2018.01.029","article-title":"Design, synthesis and bioevalucation of novel 2,3-dihydro-1H-inden-1-amine derivatives as potent and selective human monoamine oxidase B inhibitors based on rasagiline","volume":"145","author":"Xiao","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118080_bib20","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1602\/neurorx.2.4.541","article-title":"Medicinal chemical properties of successful central nervous system drugs","volume":"2","author":"Pajouhesh","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.ejmech.2025.118080_bib21","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1021\/jm501535r","article-title":"CNS drug design: balancing physicochemical properties for optimal brain exposure","volume":"58","author":"Rankovic","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118080_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav0316","article-title":"Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer's disease","volume":"5","author":"Park","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2025.118080_bib23","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1021\/acschemneuro.6b00029","article-title":"Central nervous system multiparameter optimization desirability: application in drug discovery","volume":"7","author":"Wager","year":"2016","journal-title":"ACS Chem. Neurosci."},{"issue":"W1","key":"10.1016\/j.ejmech.2025.118080_bib24","doi-asserted-by":"crossref","first-page":"W422","DOI":"10.1093\/nar\/gkae236","article-title":"ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support","volume":"52","author":"Fu","year":"2024","journal-title":"Nucleic Acids Res."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425008451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425008451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T16:40:39Z","timestamp":1772815239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425008451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":24,"alternative-id":["S0223523425008451"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118080","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological evaluation of highly potent and selective hMAO-B inhibitors featuring a tetrahydrobenzo[f][1,4]oxazepine core","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118080"}}